Site Logo

Hello, you are using an old browser that's unsafe and no longer supported. Please consider updating your browser to a newer version, or downloading a modern browser.

Frank Furnari, Ph.D.

Ludwig Institute for Cancer Research, San Diego
Sontag Scientific Advisor
2017- Present

One factor that makes glioma treatment difficult is its inherent heterogeneity promoted by different genetic drivers. Lack of models with such heterogeneity has been one obstacle for research progress. To circumvent this limitation, Dr. Furnari's lab is developing next-generation brain tumor models.

Dr. Frank Furnari is a Member of Ludwig Cancer Research Institute, Professor of Pathology at the University of California, San Diego (UCSD) and head of the Laboratory of Tumor Biology. His lab has made significant contributions to our understanding of glioma biology and therapeutic resistance. The primary focus of his research is to study fundamental pathways that drive initiation and progression of glioblastoma, as well as the malignant phenotypes of this aggressive brain cancer, ranging from tumor biology, biochemistry, cell biology, signal transduction and bioinformatic analyses, to orthotopic glioma models and preclinical investigations. His recognition in the field of glioma biology is highlighted by scholar awards from the V, Kimmel and Goldhirsh Foundations, Awards for Basic and Translational Research from the Society for Neuro-Oncology, and by his service on numerous scientific advisory boards. Dr. Furnari also serves on the editorial boards of Molecular Cancer Research and Neuro-Oncology and is co-scientific chair for the Society for Neuro-oncology annual meeting.

Current Appointments
  • Member and Head of the Laboratory of Tumor Biology, Ludwig Institute for Cancer Research
  • Professor of Pathology, University of California, San Diego.
Education
  • B.A., Biology, Hofstra University
  • Ph.D., Microbiology & Immunology, University of North Carolina, Chapel Hill